ATL adds color to ob/gyn scanner

Article

ATL Ultrasound continues to enjoy the fruits of its product development relationship with Medison of Korea. The Bothell, WA, company last week introduced a new color ob/gyn scanner, Ultramark 400C, that is the third system developed by the two

ATL Ultrasound continues to enjoy the fruits of its product development relationship with Medison of Korea. The Bothell, WA, company last week introduced a new color ob/gyn scanner, Ultramark 400C, that is the third system developed by the two companies since they signed their R&D joint venture last year.

Ultramark 400C builds on Ultramark 400, a digital grayscale system developed by Medison that ATL introduced last spring (SCAN 5/13/98). ATL believes the new scanner offers digital color imaging at a breakthrough price point for the ob/gyn segment. Color-flow ob/gyn imaging can help sonographers evaluate pelvic masses or ectopic pregnancies, and allows clinicians to more closely observe the hemodynamic status of a fetus. Meanwhile, Ultramark 400C’s grayscale capabilities support breast imaging, the company said.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.